Precipio, Inc.

PRPO · NasdaqCM · Stock · Healthcare

$22.56

+1.14% today

Delayed price, 2026-10-15 14:52 UTC

What Precipio does

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Key facts

Sector

Healthcare

Industry

Diagnostics & Research

Market cap

$40.4M

P/E (ttm)

—

Forward P/E

57.8

Dividend yield

0.00%

Beta

1.30

Profit margin

-4.5%

Employees

Headquarters

New Haven, CT, United States

Exchange

NasdaqCM

Website

www.precipiodx.com

Performance

1 Month

-14.7%

3 Months

-8.4%

6 Months

-20.3%

1 Year

+30.8%

5 Years

-41.9%

$16.4052-week range$33.63

Biggest setback — last 12 months

-30.0%

27 Apr 2026 → 27 Jul 2026

Fell from $30.94 to $21.65 — its sharpest sustained decline this year.

Biggest run-up — last 12 months

+79.4%

13 Oct 2025 → 27 Apr 2026

Ran from $17.25 to $30.94 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend

Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.

Horizon	Bear case (−1σ)	Base case	Bull case (+1σ)
1 Month	$19.02 (-15.7%)	$22.56	$26.76 (+18.6%)
3 Months	$16.79 (-25.6%)	$22.56	$30.32 (+34.4%)
6 Months	$14.85 (-34.2%)	$22.56	$34.26 (+51.9%)
12 Months	$12.49 (-44.6%)	$22.56	$40.74 (+80.6%)

Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 59.1%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

WCHD

WeCapital Holdings, Inc.

AirSculpt Technologies, Inc.

$1.42 · -0.3%

PARK

Park Dental Partners, Inc.

$18.81 · -1.0%

CCEL

Cryo-Cell International, Inc.

$4.05 · -2.4%

IDXG

Interpace Biosciences, Inc.

$5.38 · -3.8%

Recent headlines

PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? — Zacks PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now? — Zacks Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA Mark ... — GuruFocus.com

Learn the basics

What is a stock? Understanding risk and reward Why diversification matters

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.